Revlimid® (lenalidomide)
for Myelodysplastic Syndromes

Revlimid (lenalidomide) is used in adults to treat multiple myeloma, mantle cell lymphoma (MCL), follicular lymphoma (FL), marginal zone lymphoma (MZL), and anemia from myelodysplastic syndromes (MDS). It slows cancer growth, blocks new blood vessels in tumors, and boosts immune response. It’s used with dexamethasone for multiple myeloma, as maintenance after stem cell transplant, and with rituximab for FL or MZL. It also treats anemia in certain MDS patients.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Myelodysplastic Syndromes - MDS